MetLife Investment Advisors »

Denali Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 62k 21.46
2023-09-30 $1.3M 62k 20.63
2023-06-30 $1.8M 62k 29.51
2023-03-31 $1.3M 57k 23.04
2022-12-31 $1.6M 57k 27.81
2022-09-30 $1.6M 52k 30.69
2022-06-30 $1.5M 50k 29.43
2022-03-31 $1.6M 50k 32.17
2021-12-31 $1.4M 32k 44.61
2021-09-30 $1.6M 32k 50.45
2021-06-30 $2.5M 32k 78.44
2021-03-31 $1.4M 25k 57.10
2020-12-31 $2.1M 25k 83.75
2020-09-30 $1.0M 28k 35.82
2020-06-30 $680k 28k 24.19
2020-03-31 $397k 23k 17.51
2019-12-31 $364k 21k 17.42
2019-09-30 $320k 21k 15.32
2019-06-30 $434k 21k 20.75
2019-03-31 $486k 21k 23.22
2018-12-31 $432k 21k 20.66
2018-09-30 $712k 33k 21.74
2018-03-31 $246k 13k 19.73